<unk>  is a Diagnostic Agent that is<unk> DA approved<unk> or the diagnosis of Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated<unk> or Alzheimer's Disease (AD).   Common adverse reactions include Hypertension, headache, Myalgia, Nausea, Injection site reaction.
Florbetapir F-18
14-Phenylpropoxymetopon
Dihydroergocryptine
14-Ethoxymetopon
14-Methoxymetopon
Thiomersal
Catridecacog
Itramin tosilate